Antineoplastic activity of a nutrient mixture in Y-79 malignant retinoblastoma cells

M Waheed Roomi1, Nusrath Roomi, Bilwa Bhanap

  • 1Dr Rath Research Institute, Cancer Division, Santa Clara, CA 95050, USA.

Oncology Reports
|November 7, 2012
PubMed

Insights

A nutrient mixture containing lysine, proline, ascorbic acid, and green tea extract showed antineoplastic effects against retinoblastoma cells. This mixture inhibited cell proliferation and induced apoptosis, suggesting potential for treating metastatic retinoblastoma.

Area of Science:

  • Oncology
  • Cell Biology
  • Nutritional Science

Background:

  • Retinoblastoma is a common childhood eye cancer, with metastatic forms being fatal.
  • Current treatments for metastatic retinoblastoma are ineffective.
  • Investigating novel therapeutic agents is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the antineoplastic activity of a specific nutrient mixture (NM) in human retinoblastoma Y-79 cells.
  • To assess the effects of NM on cell proliferation, matrix metalloproteinase (MMP) expression, invasion, morphology, and apoptosis.
  • To determine the therapeutic potential of NM for metastatic retinoblastoma.

Main Methods:

  • Y-79 retinoblastoma cells were treated with varying concentrations of the nutrient mixture (lysine, proline, ascorbic acid, green tea extract).
  • Assays included cell viability (trypan blue), Matrigel invasion, MMP activity (zymography), morphology (H&E staining), and apoptosis (Live Green Poly Caspase Detection kit).

Main Results:

  • The nutrient mixture exhibited dose-dependent toxicity against Y-79 cells, with significant effects at higher concentrations.
  • NM inhibited MMP-2 expression at 500 µg/ml and induced morphological changes and apoptosis in Y-79 cells.
  • Y-79 cells demonstrated no invasive potential through Matrigel in this study.

Conclusions:

  • The nutrient mixture demonstrated significant antineoplastic activity by inhibiting proliferation and inducing apoptosis in retinoblastoma cells.
  • NM's ability to inhibit MMP-2 expression warrants further investigation for its role in retinoblastoma metastasis.
  • This nutrient mixture shows promise as a potential therapeutic candidate for metastatic retinoblastoma.